140 related articles for article (PubMed ID: 36538991)
1. Navigating Coronavirus Disease 2019 Vaccination and Uveitis: Identifying the Rates and Risk of Recurrent Uveitis after Coronavirus Disease Vaccination.
Jordan CA; Townend S; Allen N; Sims J; McGhee CNJ; Niederer RL
Ophthalmology; 2023 May; 130(5):501-508. PubMed ID: 36538991
[TBL] [Abstract][Full Text] [Related]
2. Risk of Noninfectious Uveitis after Coronavirus Disease 2019 Vaccination in a United States Claims Database.
Kumar A; Miller DC; Sun Y; Arnold BF; Acharya NR
Ophthalmology; 2023 Dec; 130(12):1269-1278. PubMed ID: 37480943
[TBL] [Abstract][Full Text] [Related]
3. Association between Vaccination with the BNT162b2 mRNA Coronavirus Disease 2019 Vaccine and Noninfectious Uveitis: A Population-Based Study.
Tomkins-Netzer O; Sar S; Barnett-Griness O; Friedman B; Shyriaieva H; Saliba W
Ophthalmology; 2022 Oct; 129(10):1087-1095. PubMed ID: 35643168
[TBL] [Abstract][Full Text] [Related]
4. Vaccine-Associated Uveitis after COVID-19 Vaccination: Vaccine Adverse Event Reporting System Database Analysis.
Singh RB; Parmar UPS; Kahale F; Agarwal A; Tsui E
Ophthalmology; 2023 Feb; 130(2):179-186. PubMed ID: 36055601
[TBL] [Abstract][Full Text] [Related]
5. New onset of acute uveitis following COVID-19 vaccination.
Sim HE; Hwang JH
Graefes Arch Clin Exp Ophthalmol; 2023 Feb; 261(2):555-560. PubMed ID: 35939122
[TBL] [Abstract][Full Text] [Related]
6. There Is No Evidence That Inactivated COVID-19 Vaccines Increase Risks of Uveitis Flare.
Song H; Zhao C; Zhang M
Vaccines (Basel); 2022 Oct; 10(10):. PubMed ID: 36298545
[TBL] [Abstract][Full Text] [Related]
7. Post-mRNA vaccine flares in autoimmune inflammatory rheumatic diseases: Results from the COronavirus National Vaccine registry for ImmuNe diseases SINGapore (CONVIN-SING).
Ma M; Santosa A; Fong W; Chew LC; Low AH; Law A; Poh YJ; Yeo SI; Leung YY; Ng VW; Koh JZ; Tay SH; Mak A; Teng GG; Xu C; Tang JG; Kong KO; Angkodjojo S; Goh WR; Chuah TY; Roslan NE; Arkachaisri T; Teh KL; Sriranganathan M; Tan TC; Phang KF; Yap QV; Chan YH; Cheung PP; Lahiri M
J Autoimmun; 2023 Jan; 134():102959. PubMed ID: 36473406
[TBL] [Abstract][Full Text] [Related]
8. The Association between Noninfectious Uveitis and Coronavirus Disease 2019 Outcomes: An Analysis of United States Claims-Based Data.
Miller DC; Sun Y; Chen EM; Arnold BF; Acharya NR
Ophthalmology; 2022 Mar; 129(3):334-343. PubMed ID: 34648828
[TBL] [Abstract][Full Text] [Related]
9. Intraocular inflammation following COVID-19 vaccination: the clinical presentations.
Li S; Ho M; Mak A; Lai F; Brelen M; Chong K; Young A
Int Ophthalmol; 2023 Aug; 43(8):2971-2981. PubMed ID: 37000311
[TBL] [Abstract][Full Text] [Related]
10. Noninfectious Uveitis Risk After COVID-19 Vaccination: A Nationwide Retrospective Cohort Study.
Chang MS; Kim HR; Kim S; Lee CS; Byeon SH; Kim SS; Lee SW; Kim YJ
Am J Ophthalmol; 2024 Feb; 258():22-31. PubMed ID: 37739204
[TBL] [Abstract][Full Text] [Related]
11. Uveitis Risk After the First Dose of COVID-19 Vaccination Based on Uveitis History: Matched Cohort and Crossover Case Series Study.
Kim HR; Kim S; Chang MS; Lee CS; Byeon SH; Kim SS; Lee SW; Kim YJ
Am J Ophthalmol; 2024 Jun; 262():125-133. PubMed ID: 38341167
[TBL] [Abstract][Full Text] [Related]
12. A multicenter study of ocular inflammation after COVID-19 vaccination.
Yasaka Y; Hasegawa E; Keino H; Usui Y; Maruyama K; Yamamoto Y; Kaburaki T; Iwata D; Takeuchi M; Kusuhara S; Takase H; Nagata K; Yanai R; Kaneko Y; Iwahashi C; Fukushima A; Ohguro N; Sonoda KH;
Jpn J Ophthalmol; 2023 Jan; 67(1):14-21. PubMed ID: 36417027
[TBL] [Abstract][Full Text] [Related]
13. Is vaccination against COVID-19 associated with autoimmune rheumatic disease flare? A self-controlled case series analysis.
Nakafero G; Grainge MJ; Card T; Mallen CD; Nguyen Van-Tam JS; Williams HC; Abhishek A
Rheumatology (Oxford); 2023 Apr; 62(4):1445-1450. PubMed ID: 36048896
[TBL] [Abstract][Full Text] [Related]
14. Ocular Adverse Events after Coronavirus Disease 2019 mRNA Vaccination: Matched Cohort and Self-Controlled Case Series Studies Using a Large Database.
Hashimoto Y; Yamana H; Iwagami M; Ono S; Takeuchi Y; Michihata N; Uemura K; Yasunaga H; Aihara M; Kaburaki T
Ophthalmology; 2023 Mar; 130(3):256-264. PubMed ID: 36306975
[TBL] [Abstract][Full Text] [Related]
15. Bilateral uveitis after inoculation with COVID-19 vaccine: A case report.
Pan L; Zhang Y; Cui Y; Wu X
Int J Infect Dis; 2021 Dec; 113():116-118. PubMed ID: 34601147
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory ocular events after inactivated COVID-19 vaccination.
Fei P; Feng H; Li J; Liu M; Luo J; Ye H; Zhao P
Hum Vaccin Immunother; 2022 Nov; 18(6):2138051. PubMed ID: 36369840
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 Vaccination and Uveitis: Epidemiology, Clinical Features and Visual Prognosis.
Ferrand N; Accorinti M; Agarwal M; Spartalis C; Manni P; Stuebiger N; Zierhut M
Ocul Immunol Inflamm; 2022 Jul; 30(5):1265-1273. PubMed ID: 35404757
[TBL] [Abstract][Full Text] [Related]
18. Optic Neuritis and Cranial Neuropathies Diagnosis Rates before Coronavirus Disease 2019, in the Initial Pandemic Phase, and Post-Vaccine Introduction.
Zhao D; Li X; Carey AR; Henderson AD;
Ophthalmology; 2024 Jan; 131(1):78-86. PubMed ID: 37634758
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
20. Risk for uveitis relapse after COVID-19 vaccination.
Zhong Z; Wu Q; Lai Y; Dai L; Gao Y; Liao W; Feng X; Yang P
J Autoimmun; 2022 Dec; 133():102925. PubMed ID: 36209692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
